Literature DB >> 18832772

A sensitive and specific ELISA detects methionine sulfoxide-containing apolipoprotein A-I in HDL.

Xiao Suo Wang1, Baohai Shao2, Michael N Oda3, Jay W Heinecke2, Stephen Mahler4, Roland Stocker5.   

Abstract

Oxidized HDL has been proposed to play a key role in atherogenesis. A wide range of reactive intermediates oxidizes methionine residues to methionine sulfoxide (MetO) in apolipoprotein A-I (apoA-I), the major HDL protein. These reactive species include those produced by myeloperoxidase, an enzyme implicated in atherogenesis. The aim of the present study was to develop a sensitive and specific ELISA for detecting MetO residues in HDL. We therefore immunized mice with HPLC-purified human apoA-I containing MetO(86) and MetO(112) (termed apoA-I(+32)) to generate a monoclonal antibody termed MOA-I. An ELISA using MOA-I detected lipid-free apoA-I(+32), apoA-I modified by 2e-oxidants (hydrogen peroxide, hypochlorous acid, peroxynitrite), and HDL oxidized by 1e- or 2e-oxidants and present in buffer or human plasma. Detection was concentration dependent, reproducible, and exhibited a linear response over a physiologically plausible range of concentrations of oxidized HDL. In contrast, MOA-I failed to recognize native apoA-I, native apoA-II, apoA-I modified by hydroxyl radical or metal ions, or LDL and methionine-containing proteins other than apoA-I modified by 2e-oxidants. Because the ELISA we have developed specifically detects apoA-I containing MetO in HDL and plasma, it should provide a useful tool for investigating the relationship between oxidized HDL and coronary artery disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18832772      PMCID: PMC2638111          DOI: 10.1194/jlr.D800042-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  32 in total

1.  Immunochemical detection of circulating oxidized high-density lipoprotein with antioxidized apolipoprotein A-I monoclonal antibody.

Authors:  Takanari Nakano; Atsuo Nagata
Journal:  J Lab Clin Med       Date:  2003-06

Review 2.  Role of oxidative modifications in atherosclerosis.

Authors:  Roland Stocker; John F Keaney
Journal:  Physiol Rev       Date:  2004-10       Impact factor: 37.312

Review 3.  Antiinflammatory properties of HDL.

Authors:  Philip J Barter; Stephen Nicholls; Kerry-Anne Rye; G M Anantharamaiah; Mohamad Navab; Alan M Fogelman
Journal:  Circ Res       Date:  2004-10-15       Impact factor: 17.367

4.  Oxidation of methionine residues to methionine sulfoxides does not decrease potential antiatherogenic properties of apolipoprotein A-I.

Authors:  U Panzenböck; L Kritharides; M Raftery; K A Rye; R Stocker
Journal:  J Biol Chem       Date:  2000-06-30       Impact factor: 5.157

5.  The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport.

Authors:  Constanze Bergt; Subramaniam Pennathur; Xiaoyun Fu; Jaeman Byun; Kevin O'Brien; Thomas O McDonald; Pragya Singh; G M Anantharamaiah; Alan Chait; John Brunzell; Randolph L Geary; John F Oram; Jay W Heinecke
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-23       Impact factor: 11.205

6.  Characterization of specifically oxidized apolipoproteins in mildly oxidized high density lipoprotein.

Authors:  Greg Pankhurst; Xing Li Wang; David E Wilcken; Georg Baernthaler; Ute Panzenböck; Mark Raftery; Roland Stocker
Journal:  J Lipid Res       Date:  2002-11-04       Impact factor: 5.922

7.  Characterization of the epitopes specific for the monoclonal antibody 9F5-3a and quantification of oxidized HDL in human plasma.

Authors:  Takanori Nakajima; Toshiyuki Matsunaga; Shin-Ichiroh Kawai; Shigeru Hokari; Ikuo Inoue; Shigehiro Katayama; Atsuo Nagata; Tsugikazu Komoda
Journal:  Ann Clin Biochem       Date:  2004-07       Impact factor: 2.057

8.  Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease.

Authors:  Lemin Zheng; Benedicta Nukuna; Marie-Luise Brennan; Mingjiang Sun; Marlene Goormastic; Megan Settle; Dave Schmitt; Xiaoming Fu; Leonor Thomson; Paul L Fox; Harry Ischiropoulos; Jonathan D Smith; Michael Kinter; Stanley L Hazen
Journal:  J Clin Invest       Date:  2004-08       Impact factor: 14.808

9.  Reduction of phosphatidylcholine hydroperoxide by apolipoprotein A-I: purification of the hydroperoxide-reducing proteins from human blood plasma.

Authors:  R Mashima; Y Yamamoto; S Yoshimura
Journal:  J Lipid Res       Date:  1998-06       Impact factor: 5.922

10.  Human atherosclerotic intima and blood of patients with established coronary artery disease contain high density lipoprotein damaged by reactive nitrogen species.

Authors:  Subramaniam Pennathur; Constanze Bergt; Baohai Shao; Jaeman Byun; Sean Y Kassim; Pragya Singh; Pattie S Green; Thomas O McDonald; John Brunzell; Alan Chait; John F Oram; Kevin O'brien; Randolph L Geary; Jay W Heinecke
Journal:  J Biol Chem       Date:  2004-08-02       Impact factor: 5.157

View more
  10 in total

1.  A biochemical fluorometric method for assessing the oxidative properties of HDL.

Authors:  Theodoros Kelesidis; Judith S Currier; Diana Huynh; David Meriwether; Christina Charles-Schoeman; Srinivasa T Reddy; Alan M Fogelman; Mohamad Navab; Otto O Yang
Journal:  J Lipid Res       Date:  2011-09-27       Impact factor: 5.922

2.  Serum amyloid A in uremic HDL promotes inflammation.

Authors:  Thomas Weichhart; Chantal Kopecky; Markus Kubicek; Michael Haidinger; Dominik Döller; Karl Katholnig; Cacang Suarna; Philipp Eller; Markus Tölle; Christopher Gerner; Gerhard J Zlabinger; Markus van der Giet; Walter H Hörl; Roland Stocker; Marcus D Säemann
Journal:  J Am Soc Nephrol       Date:  2012-01-26       Impact factor: 10.121

3.  Elevated plasma albumin and apolipoprotein A-I oxidation under suboptimal specimen storage conditions.

Authors:  Chad R Borges; Douglas S Rehder; Sally Jensen; Matthew R Schaab; Nisha D Sherma; Hussein Yassine; Boriana Nikolova; Christian Breburda
Journal:  Mol Cell Proteomics       Date:  2014-04-15       Impact factor: 5.911

4.  Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein.

Authors:  Shubhendu Sen Roy; Huy Cong Xuan Nguyen; Thomas A Angelovich; Anna C Hearps; Diana Huynh; Anthony Jaworowski; Theodoros Kelesidis
Journal:  J Vis Exp       Date:  2017-10-12       Impact factor: 1.355

5.  Effects of lipid-probe interactions in biochemical fluorometric methods that assess HDL redox activity.

Authors:  Theodoros Kelesidis; Srinivasa T Reddy; Diana Huynh; David Meriwether; Alan M Fogelman; Mohamad Navab; Otto O Yang
Journal:  Lipids Health Dis       Date:  2012-07-06       Impact factor: 4.315

6.  Hepatic overexpression of methionine sulfoxide reductase A reduces atherosclerosis in apolipoprotein E-deficient mice.

Authors:  Yan-Yong Xu; Fen Du; Bing Meng; Guang-Hui Xie; Jia Cao; Daping Fan; Hong Yu
Journal:  J Lipid Res       Date:  2015-08-28       Impact factor: 5.922

7.  A high throughput biochemical fluorometric method for measuring lipid peroxidation in HDL.

Authors:  Theodoros Kelesidis; Christian K Roberts; Diana Huynh; Otoniel Martínez-Maza; Judith S Currier; Srinivasa T Reddy; Otto O Yang
Journal:  PLoS One       Date:  2014-11-04       Impact factor: 3.752

8.  Plasma HDL reduces nonesterified fatty acid hydroperoxides originating from oxidized LDL: a mechanism for its antioxidant ability.

Authors:  Mari Kotosai; Sachiko Shimada; Mai Kanda; Namiko Matsuda; Keiko Sekido; Yoshibumi Shimizu; Akira Tokumura; Toshiyuki Nakamura; Kaeko Murota; Yoshichika Kawai; Junji Terao
Journal:  Lipids       Date:  2013-03-14       Impact factor: 1.880

9.  Characterization of methionine oxidation and methionine sulfoxide reduction using methionine-rich cysteine-free proteins.

Authors:  Xinwen Liang; Alaattin Kaya; Yan Zhang; Dung Tien Le; Deame Hua; Vadim N Gladyshev
Journal:  BMC Biochem       Date:  2012-10-23       Impact factor: 4.059

10.  Development and Clinical Application of an Enzyme-Linked Immunosorbent Assay for Oxidized High-Density Lipoprotein.

Authors:  Takeshi Okada; Mizuki Sumida; Tohru Ohama; Yuki Katayama; Ayami Saga; Hiroyasu Inui; Kotaro Kanno; Daisaku Masuda; Masahiro Koseki; Makoto Nishida; Yasushi Sakata; Shizuya Yamashita
Journal:  J Atheroscler Thromb       Date:  2020-10-17       Impact factor: 4.928

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.